Editorial: Cancer genomics in the era of precision medicine
<p dir="ltr">Cancer is a multifactorial disease driven by genetic and environmental factors, affecting a range of biological processes which regulate cell proliferation and survival. Advancements in sequencing technology and big data analysis have made genomics a key pillar of cancer...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513509833834496 |
|---|---|
| author | Omar M. Khan (17807774) |
| author2 | Domenico Mallardo (5520296) Julie Decock (44558) |
| author2_role | author author |
| author_facet | Omar M. Khan (17807774) Domenico Mallardo (5520296) Julie Decock (44558) |
| author_role | author |
| dc.creator.none.fl_str_mv | Omar M. Khan (17807774) Domenico Mallardo (5520296) Julie Decock (44558) |
| dc.date.none.fl_str_mv | 2024-02-16T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3389/fgene.2024.1378917 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Editorial_Cancer_genomics_in_the_era_of_precision_medicine/26355097 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Oncology and carcinogenesis cancer genomics precision medicine epigenetics biomarkers diagnostics predictive value |
| dc.title.none.fl_str_mv | Editorial: Cancer genomics in the era of precision medicine |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">Cancer is a multifactorial disease driven by genetic and environmental factors, affecting a range of biological processes which regulate cell proliferation and survival. Advancements in sequencing technology and big data analysis have made genomics a key pillar of cancer research, providing insights into disease etiology, disease risk and treatment resistance mechanisms. In the clinical setting, cancer genomics is currently used to determine hereditary cancer risk, predict prognosis, and inform treatment selection.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Genetics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fgene.2024.1378917" target="_blank">https://dx.doi.org/10.3389/fgene.2024.1378917</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_8afe05d8645a07b5f45bcd25116719bf |
| identifier_str_mv | 10.3389/fgene.2024.1378917 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/26355097 |
| publishDate | 2024 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Editorial: Cancer genomics in the era of precision medicineOmar M. Khan (17807774)Domenico Mallardo (5520296)Julie Decock (44558)Biological sciencesGeneticsBiomedical and clinical sciencesClinical sciencesOncology and carcinogenesiscancer genomicsprecision medicineepigeneticsbiomarkersdiagnosticspredictive value<p dir="ltr">Cancer is a multifactorial disease driven by genetic and environmental factors, affecting a range of biological processes which regulate cell proliferation and survival. Advancements in sequencing technology and big data analysis have made genomics a key pillar of cancer research, providing insights into disease etiology, disease risk and treatment resistance mechanisms. In the clinical setting, cancer genomics is currently used to determine hereditary cancer risk, predict prognosis, and inform treatment selection.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Genetics<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fgene.2024.1378917" target="_blank">https://dx.doi.org/10.3389/fgene.2024.1378917</a></p>2024-02-16T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fgene.2024.1378917https://figshare.com/articles/journal_contribution/Editorial_Cancer_genomics_in_the_era_of_precision_medicine/26355097CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/263550972024-02-16T09:00:00Z |
| spellingShingle | Editorial: Cancer genomics in the era of precision medicine Omar M. Khan (17807774) Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Oncology and carcinogenesis cancer genomics precision medicine epigenetics biomarkers diagnostics predictive value |
| status_str | publishedVersion |
| title | Editorial: Cancer genomics in the era of precision medicine |
| title_full | Editorial: Cancer genomics in the era of precision medicine |
| title_fullStr | Editorial: Cancer genomics in the era of precision medicine |
| title_full_unstemmed | Editorial: Cancer genomics in the era of precision medicine |
| title_short | Editorial: Cancer genomics in the era of precision medicine |
| title_sort | Editorial: Cancer genomics in the era of precision medicine |
| topic | Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Oncology and carcinogenesis cancer genomics precision medicine epigenetics biomarkers diagnostics predictive value |